Fibronectin Type III and SPRY Domain Containing 1 (FSD1) (C-Term) Peptide
-
- Target See all FSD1 products
- FSD1 (Fibronectin Type III and SPRY Domain Containing 1 (FSD1))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- FKTRFTQPLL PAFTVWCGSF QVTTGLQVPS AVRCLQKRGS ATSSSNTSLT
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-FSD1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- FSD1 (Fibronectin Type III and SPRY Domain Containing 1 (FSD1))
- Synonyms
- GLFND Peptide, MIR1 Peptide, si:ch211-232d19.3 Peptide, fibronectin type 3 and SPRY domain-containing protein Peptide, fibronectin type III and SPRY domain containing 1 Peptide, Fsd1 Peptide, FSD1 Peptide, fsd1 Peptide
- Background
-
This gene encodes a centrosome associated protein that is characterized by an N-terminal coiled-coil region downstream of B-box (BBC) domain, a central fibronectin type III domain, and a C-terminal repeats in splA and RyR (SPRY) domain. The encoded protein associates with a subset of microtubules and may be involved in the stability and organization of microtubules during cytokinesis.
Alias Symbols: FSD1,GLFND,MIR1,VLP27,
Protein Size: 496 - Gene ID
- 79187
- NCBI Accession
- NP_077309
- UniProt
- Q9BTV5
-